apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Abritiga 250 mg Tablet 30's

  3. Abritiga 250 mg Tablet 30's Substitute

Abritiga 250 mg Tablet 30's Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

ABIRATERONE-250MG

Uses:

<p>Abritiga 250 mg Tablet 30's is used in the treatment of prostate cancer. The detailed uses of Abritiga 250 mg Tablet 30's are as follows:</p><ul><li><strong>Treats advanced prostate cancer:</strong> Abritiga 250 mg Tablet 30's lowers levels of certain hormones (androgens) that fuel the growth of prostate cancer cells.</li><li><strong>Slows cancer progression:</strong> Abritiga 250 mg Tablet 30's helps delay the spread and worsening of prostate cancer.</li><li><strong>Improves overall management of prostate cancer:</strong> Abritiga 250 mg Tablet 30's is often used along with other medicines to enhance treatment effectiveness.</li></ul>

Medicinal Benefits:

Abritiga 250 mg Tablet 30's belongs to the group of medicines called androgen biosynthesis inhibitors, indicated in combination with prednisone or prednisolone to treat prostate cancer in adult men that have spread to other body parts. Abritiga 250 mg Tablet 30's contains ‘Abiraterone’ that works by stopping the body from making testosterone, thereby slowing the growth of prostate cancer. It is indicated in patients with metastatic castration-resistant prostate cancer (CRPC) who have received prior chemotherapy containing docetaxel and metastatic high-risk castration-sensitive prostate cancer (CSPC). Abritiga 250 mg Tablet 30's is prescribed in the early stages of the disease, where it is still responding to hormone therapy. It is used with androgen deprivation therapy (a treatment that lowers testosterone).

FAQs

Abritiga 250 mg Tablet 30's is used to treat Prostate cancer.

Abritiga 250 mg Tablet 30's works by stopping the body from making testosterone, thereby slowing the growth of prostate cancer.

Prednisolone/prednisone is prescribed along with Abritiga 250 mg Tablet 30's to lower the chances of getting high blood pressure, fluid retention (having too much water in the body), or low blood potassium levels.

Abritiga 250 mg Tablet 30's should not be given along with Ra-233 (a radioactive isotope used to treat prostate cancer) due to the increased risk of bone fracture or death. If you are prescribed to take Ra-233 following treatment with Abritiga 250 mg Tablet 30's and prednisolone/prednisone, you must wait five days before starting treatment with Ra-233.

No, Abritiga 250 mg Tablet 30's cannot cure prostate cancer. However, it is used to manage advanced or metastatic prostate cancer that works by inhibiting the production of testosterone, thereby preventing the growth and spread of cancer.

No, Abritiga 250 mg Tablet 30's is not a chemotherapy drug. It is a hormone therapy medication, which reduces testosterone levels to help manage prostate cancer.

Yes, Abritiga 250 mg Tablet 30's may affect the liver. Therefore, the doctor may advise regular blood tests to monitor its effects on the liver.

For patients taking Abritiga 250 mg Tablet 30's liver investigations are recommended. However, the frequency may differ for each individual and can be determined by the doctor based on your medical condition.

Abritiga 250 mg Tablet 30's can be taken orally on an empty stomach, either 1 hour before a meal or 2 hours after the meal. Swallow it as a whole with a glass of water. Do not chew or break it.

The side effects of Abritiga 250 mg Tablet 30's include oedema, urinary tract infection, high blood pressure, low blood potassium, and diarrhoea. Consult the doctor if any of these symptoms persist or worsen.

Apollo 247 Floating Button